Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood in a smart menstrual pad. In other words, can the investigators detect the high risk strains of the human papilloma virus (HPV) that are associated with cervical cancer in self-collected menstrual blood, as an alternative to collecting vaginal swabs.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03638427
Study type Observational
Source Stanford University
Contact
Status Enrolling by invitation
Phase
Start date January 1, 2019
Completion date January 1, 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT03445416 - Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men N/A
Completed NCT03474211 - Prevalence of HPV Infection Using Self-sampling
Recruiting NCT05973487 - A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors Phase 1
Recruiting NCT03789513 - Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women N/A
Active, not recruiting NCT03391921 - Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) Phase 4
Recruiting NCT03357991 - E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSM N/A